David Barthel - Nov 10, 2021 Form 3 Insider Report for MARIZYME INC (MRZM)

Role: Chief Executive Officer, Director
Signature: /s/ David Barthel
Stock symbol: MRZM
Transactions as of: Nov 10, 2021
Transactions value $: $0
Form type: 3
Date filed: 1/6/2022, 12:27 PM
Next filing: Feb 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MRZM	Employee Stock Option (Right to Buy)							Nov 10, 2021	Common Stock	400K	$2.25	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option is vested as to 40,000 shares upon grant on October 31, 2021 pursuant to the Executive Employment Agreement between the reporting person and the issuer dated as of October 31, 2021. The balance of 360,000 shares will vest on a quarterly basis over the three (3) year period following the grant date in equal installments. The reporting person was appointed as Chief Executive Officer of the issuer on November 10, 2021 and as a director of the issuer on December 20, 2021.

Content

The option is vested as to 40,000 shares upon grant on October 31, 2021 pursuant to the Executive Employment Agreement between the reporting person and the issuer dated as of October 31, 2021. The balance of 360,000 shares will vest on a quarterly basis over the three (3) year period following the grant date in equal installments. The reporting person was appointed as Chief Executive Officer of the issuer on November 10, 2021 and as a director of the issuer on December 20, 2021.